The effects of combined atorvastatin and amlodipine on blood pressure (BP) and low-
density lipoprotein (LDL) cholesterol levels were investigated in 134 patients with …

Hypertension (HTN) and dyslipidemia (DYS) commonly coexist. Patients with concurrent
HTN and DYS are at high risk of cardiovascular disease, yet most patients do not achieve …

Guidelines stress the importance of the simultaneous management of multiple
cardiovascular risk factors. This can in part be achieved by coadministration of lipid …

The AVALON study was a randomized, multicenter trial to assess the efficacy and safety of
coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia …

Amlodipine/atorvastatin (Caduet®) is a once-daily fixed-dose combination of the
dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase …

Amlodipine/atorvastatin (Caduet®) is a single-tablet, fixed-dose combination of the
dihydropyridine calcium channel antagonist amlodipine and the HMG-CoA reductase …

The efficacy and safety of atorvastatin 10 mg versus simvastatin 20 mg and atorvastatin 80
mg versus simvastatin 80 mg was determined in a 6-week, prospective, randomized, open …

Hypertension and dyslipidemia are two of the most commonly co-occurring cardiovascular
risk factors which together cause an increase in coronary heart disease-related events that …

This double-blind study to evaluate long-term efficacy and safety of atorvastatin was
performed in 31 community-and university-based research centers in the USA to directly …

Therapies that lower blood pressure or lipid levels slow the progression of atherosclerosis,
and reduce morbidity and mortality in patients with hypertension or atherosclerotic disease …